Douglas A Treco, President & CEO, Director at Ra Pharmaceuticals, holds 22.00K shares in Crispr Therapeutics AG (Ticker: CRSP), holds 0.00 shares in Inozyme Pharma (Ticker: INZY), holds 0.00 shares in Ra Pharmaceuticals (Ticker: RARX). Most recently, Douglas A Treco Bought ― shares of Crispr Therapeutics AG on Aug 08, 2025 for an estimated value of $1.14M.
What is the percentage of profitable transactions made by Douglas A Treco?
The percentage of profitable transactions made by Douglas A Treco is ―.
What is the average return per transaction made by Douglas A Treco?
The average return per transaction made by Douglas A Treco is ―.
What stocks does Douglas A Treco hold?
Douglas A Treco holds: RARX, CRSP, INZY stocks.
What was Douglas A Treco’s latest transaction?
Douglas A Treco latest transaction was an Informative Buy of $1.14M.
What was Douglas A Treco's most profitable transaction?
Douglas A Treco’s most profitable transaction was an Informative Buy of CRSP stock on August 8, 2025. The return on the trade was 0.00%.
What is Douglas A Treco's role in Ra Pharmaceuticals?
Douglas A Treco's role in Ra Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.